These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 1750727

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of intranasal challenge with interleukin-6 on upper airway symptomatology and physiology in allergic and nonallergic patients.
    Gentile DA, Yokitis J, Angelini BL, Doyle WJ, Skoner DP.
    Ann Allergy Asthma Immunol; 2001 May; 86(5):531-6. PubMed ID: 11379804
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of intranasal histamine on the cough reflex in subjects with allergic rhinitis.
    Plevkova J, Brozmanova M, Pecova R, Tatar M.
    J Physiol Pharmacol; 2005 Sep; 56 Suppl 4():185-95. PubMed ID: 16204792
    [Abstract] [Full Text] [Related]

  • 6. Experimentally induced nasal hypersecretion does not reduce the efficacy of intranasal levocabastine.
    Borum S, Nielsen K, Bisgaard H, Mygind N.
    Rhinology; 1998 Dec; 36(4):153-5. PubMed ID: 9923056
    [Abstract] [Full Text] [Related]

  • 7. Topical azelastine has a 12-hour duration of action as assessed by histamine challenge-induced exudation of alpha 2-macroglobulin into human nasal airways.
    Greiff L, Andersson M, Svensson C, Persson CG.
    Clin Exp Allergy; 1997 Apr; 27(4):438-44. PubMed ID: 9146938
    [Abstract] [Full Text] [Related]

  • 8. Effects of intranasal azelastine on the response to nasal allergen challenge.
    Saengpanich S, Assanasen P, deTineo M, Haney L, Naclerio RM, Baroody FM.
    Laryngoscope; 2002 Jan; 112(1):47-52. PubMed ID: 11802037
    [Abstract] [Full Text] [Related]

  • 9. Terfenadine, an H1 antihistamine, inhibits histamine release in vivo in the human.
    Naclerio RM, Kagey-Sobotka A, Lichtenstein LM, Freidhoff L, Proud D.
    Am Rev Respir Dis; 1990 Jul; 142(1):167-71. PubMed ID: 1695070
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A placebo-controlled evaluation of butterbur and fexofenadine on objective and subjective outcomes in perennial allergic rhinitis.
    Lee DK, Gray RD, Robb FM, Fujihara S, Lipworth BJ.
    Clin Exp Allergy; 2004 Apr; 34(4):646-9. PubMed ID: 15080820
    [Abstract] [Full Text] [Related]

  • 12. Effects of single or combined histamine H1-receptor and leukotriene CysLT1-receptor antagonism on nasal adenosine monophosphate challenge in persistent allergic rhinitis.
    Lee DK, Jackson CM, Soutar PC, Fardon TC, Lipworth BJ.
    Br J Clin Pharmacol; 2004 Jun; 57(6):714-9. PubMed ID: 15151516
    [Abstract] [Full Text] [Related]

  • 13. Eustachian tube obstruction (ETO) after histamine nasal provocation--a double-blind dose-response study.
    Skoner DP, Doyle WJ, Fireman P.
    J Allergy Clin Immunol; 1987 Jan; 79(1):27-31. PubMed ID: 3805544
    [Abstract] [Full Text] [Related]

  • 14. Interactive effect of histamine and prostaglandin D2 on nasal allergic symptoms in rats.
    Rahman A, Inoue T, Ago J, Ishikawa T, Kamei C.
    Eur J Pharmacol; 2007 Jan 12; 554(2-3):229-34. PubMed ID: 17112500
    [Abstract] [Full Text] [Related]

  • 15. Mizolastine and fexofenadine modulate cytokine pattern after nasal allergen challenge.
    Ciprandi G, Cirillo I, Vizzaccaro A.
    Eur Ann Allergy Clin Immunol; 2004 Apr 12; 36(4):146-50. PubMed ID: 15180356
    [Abstract] [Full Text] [Related]

  • 16. Effect of terfenadine on nasal provocation.
    Jankowski R, Wagenmann M, Baroody FM, Naclerio R.
    Int Arch Allergy Immunol; 1993 Apr 12; 101(3):311-7. PubMed ID: 8324394
    [Abstract] [Full Text] [Related]

  • 17. The effect of terfenadine on unilateral nasal challenge with allergen.
    Wagenmann M, Baroody FM, Kagey-Sobotka A, Lichtenstein LM, Naclerio RM.
    J Allergy Clin Immunol; 1994 Mar 12; 93(3):594-605. PubMed ID: 7512101
    [Abstract] [Full Text] [Related]

  • 18. Reproducibility of the effects of intranasal ragweed challenges in allergic subjects.
    Doyle WJ, Skoner DP, Seroky JT, Fireman P.
    Ann Allergy Asthma Immunol; 1995 Feb 12; 74(2):171-6. PubMed ID: 7697479
    [Abstract] [Full Text] [Related]

  • 19. Role of kinins in seasonal allergic rhinitis: icatibant, a bradykinin B2 receptor antagonist, abolishes the hyperresponsiveness and nasal eosinophilia induced by antigen.
    Turner P, Dear J, Scadding G, Foreman JC.
    J Allergy Clin Immunol; 2001 Jan 12; 107(1):105-13. PubMed ID: 11149999
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of intranasally applied dimethindene maleate solution as spray in adult volunteers with symptoms of seasonal allergic rhinitis in the Vienna challenge chamber.
    Kyrein HJ, Horak F, Nirnberger G, Rehn D.
    Arzneimittelforschung; 1996 Aug 12; 46(8):794-9. PubMed ID: 9125281
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.